Annual EBITDA
-$408.41M$473.98M-722.84%
Summary
- Current Value
- As of today, OSCR annual EBITDA is -$408.41M, down -722.84% on
- Historical Performance
- OSCR annual EBITDA is up +31.34% over the past 3 years, down -3.53% over the past 5 years
- All-Time High Comparison
- OSCR annual EBITDA is currently -722.84% below its historical high of $65.57M set on
- 3-Year Low Comparison
- OSCR annual EBITDA is +31.34% above its 3-year low of -$594.79M reached on an earlier date
- Sector Comparison
- OSCR annual EBITDA is higher than 2.29% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$408.41M | -722.8% | +31.3% | -3.5% | -61.8% | |
| Quarterly EBITDA | $389.04M | +271.7% | +7252.8% | +662.6% | +516.5% | |
| TTM EBITDA | $618.05M | +611.2% | +236.5% | +247.9% | +761.7% | |
| Price | $32.44 | +80.9% | +427.5% | +85.5% | – | |
| PE Ratio | 23.69 | – | – | – | – | |
| Annual Revenue | $11.70B | +27.5% | +195.2% | +2428.4% | +2296.9% | |
| Annual EPS | -$1.69 | -1864.8% | +40.8% | +0.7% | -54.8% | |
| -$437.30M | -1408.3% | +28.3% | -7.8% | -68.6% | ||
| Annual Net Income | -$442.90M | -1795.6% | +27.3% | -8.9% | -69.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $65.57M | -722.8% | |
| 5Y | $65.57M | -722.8% | |
| All | $65.57M | -722.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$594.79M | N/A | +31.3% |
| 5Y | -$594.79M | +31.3% | |
| All | -$594.79M | +31.3% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$408.41M | -722.8% | |
| $65.57M | +127.7% | |
| -$236.61M | +60.2% | |
| -$594.79M | -7.0% |
| Year | Value | Change |
|---|---|---|
| -$555.98M | -40.9% | |
| -$394.50M | -56.2% | |
| -$252.49M | - |
FAQ
- What is the current annual EBITDA of OSCR?
- As of today, OSCR annual EBITDA is -$408.41M
- What is 1-year change in OSCR annual EBITDA?
- OSCR annual EBITDA is down -722.84% year-over-year
- What is 3-year change in OSCR annual EBITDA?
- OSCR annual EBITDA is up +31.34% over the past 3 years
- How far is OSCR annual EBITDA from its all-time high?
- OSCR annual EBITDA is currently -722.84% below its historical high of $65.57M set on December 31, 2024
- How does OSCR annual EBITDA rank versus sector peers?
- OSCR annual EBITDA is higher than 2.29% of companies in Healthcare sector
- When is OSCR next annual earnings release?
- As of today, the next annual earnings release for OSCR has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$389.04M$316.75M-44.88%
Summary
- Current Value
- As of today, OSCR quarterly EBITDA is $389.04M, down -44.88% on
- Historical Performance
- OSCR quarterly EBITDA is up +271.71% year-over-year, up +7252.82% over the past 3 years
- All-Time High Comparison
- OSCR quarterly EBITDA is currently -44.88% below its historical high of $705.79M set on
- 3-Year Low Comparison
- OSCR quarterly EBITDA is +212.83% above its 3-year low of -$344.80M reached on
- Sector Comparison
- OSCR quarterly EBITDA is higher than 94.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $389.04M | -44.9% | +271.7% | +7252.8% | +662.6% | |
| Annual EBITDA | -$408.41M | – | -722.8% | +31.3% | -3.5% | |
| TTM EBITDA | $618.05M | +10000.0% | +611.2% | +236.5% | +247.9% | |
| Price | $32.44 | +13.6% | +80.9% | +427.5% | +85.5% | |
| PE Ratio | 23.69 | – | – | – | – | |
| Quarterly Revenue | $4.88B | +5.0% | +70.4% | +220.7% | +822.0% | |
| Quarterly EPS | $1.09 | -47.3% | +221.4% | +1632.6% | +407.1% | |
| $383.01M | -45.2% | +264.0% | +2785.7% | +626.6% | ||
| Quarterly Net Income | $361.83M | -46.7% | +258.4% | +2445.7% | +593.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $705.79M | -44.9% | |
| 3Y | $705.79M | -44.9% | |
| 5Y | $705.79M | -44.9% | |
| All | $705.79M | -44.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$344.80M | +212.8% | |
| 3Y | -$344.80M | +212.8% | |
| 5Y | -$344.80M | +212.8% | |
| All | -$344.80M | +212.8% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of OSCR?
- As of today, OSCR quarterly EBITDA is $389.04M
- What is OSCR quarterly EBITDA most recent change?
- OSCR quarterly EBITDA was down -44.88% on June 30, 2026
- What is 1-year change in OSCR quarterly EBITDA?
- OSCR quarterly EBITDA is up +271.71% year-over-year
- How far is OSCR quarterly EBITDA from its all-time high?
- OSCR quarterly EBITDA is currently -44.88% below its historical high of $705.79M set on March 31, 2026
- How does OSCR quarterly EBITDA rank versus sector peers?
- OSCR quarterly EBITDA is higher than 94.13% of companies in Healthcare sector
- When is OSCR next earnings release?
- The next earnings release for OSCR is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$618.05M$615.61M+25,178.24%
Summary
- Current Value
- As of today, OSCR TTM EBITDA is $618.05M, up +25178.24% on
- Historical Performance
- OSCR TTM EBITDA is up +611.24% year-over-year, up +236.51% over the past 3 years
- All-Time High Comparison
- OSCR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- OSCR TTM EBITDA is +236.51% above its 3-year low of -$452.75M reached on an earlier date
- Sector Comparison
- OSCR TTM EBITDA is higher than 90.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $618.05M | +10000.0% | +611.2% | +236.5% | +247.9% | |
| Annual EBITDA | -$408.41M | – | -722.8% | +31.3% | -3.5% | |
| Quarterly EBITDA | $389.04M | -44.9% | +271.7% | +7252.8% | +662.6% | |
| Price | $32.44 | +13.6% | +80.9% | +427.5% | +85.5% | |
| PE Ratio | 23.69 | – | – | – | – | |
| TTM Revenue | $15.32B | +15.2% | +42.8% | +208.6% | +1222.8% | |
| TTM EPS | $1.37 | +324.6% | +267.1% | +161.9% | +169.8% | |
| $589.81M | +2306.1% | +489.8% | +224.3% | +236.8% | ||
| TTM Net Income | $550.93M | +1498.8% | +442.9% | +215.9% | +227.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $618.05M | at high | |
| 3Y | $618.05M | at high | |
| 5Y | $618.05M | at high | |
| All | $618.05M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$408.41M | +251.3% | |
| 3Y | -$452.75M | N/A | +236.5% |
| 5Y | -$594.79M | +203.9% | |
| All | -$594.79M | +203.9% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of OSCR?
- As of today, OSCR TTM EBITDA is $618.05M
- What is OSCR TTM EBITDA most recent change?
- OSCR TTM EBITDA was up +25178.24% on June 30, 2026
- What is 1-year change in OSCR TTM EBITDA?
- OSCR TTM EBITDA is up +611.24% year-over-year
- How far is OSCR TTM EBITDA from its all-time high?
- OSCR TTM EBITDA is currently at its all-time high
- How does OSCR TTM EBITDA rank versus sector peers?
- OSCR TTM EBITDA is higher than 90.92% of companies in Healthcare sector
- When is OSCR next earnings release?
- The next earnings release for OSCR is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- OSCR Official Website www.hioscar.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1568651/000156865126000011/0001568651-26-000011-index.htm
- OSCR Profile on Yahoo Finance finance.yahoo.com/quote/OSCR
- OSCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/oscr